ELV - Elevance Health - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ELV is currently covered by 15 analysts with an average price target of $356.86. This is a potential upside of $80.41 (29.09%) from yesterday's end of day stock price of $276.45.

Elevance Health's activity chart (see below) currently has 299 price targets and 242 ratings on display. The stock rating distribution of ELV is 98.72% BUY and 1.28% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.57% with an average time for these price targets to be met of 311.42 days.

Highest price target for ELV is $615, Lowest price target is $310, average price target is $479.08.

Most recent stock forecast was given by ANDREW MOK from BARCLAYS on 18-Jul-2025. First documented stock forecast 06-Jan-2015.

Currently out of the existing stock ratings of ELV, 77 are a BUY (98.72%), 1 are a HOLD (1.28%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$358

$80.91 (29.20%)

$434

3 days ago
(18-Jul-2025)

0/9 (0%)

$80.91 (29.20%)

Buy

$310

$32.91 (11.88%)

$515

3 days ago
(18-Jul-2025)

11/16 (68.75%)

$32.91 (11.88%)

203

Buy

$440

$162.91 (58.79%)

$500

5 days ago
(16-Jul-2025)

9/18 (50%)

$95.45 (27.70%)

420

Buy

$478

$200.91 (72.51%)

$478

1 months 17 days ago
(04-Jun-2025)

2/10 (20%)

$97.93 (25.77%)

272

Buy

$485

$207.91 (75.03%)

$485

2 months 28 days ago
(23-Apr-2025)

10/22 (45.45%)

$58.13 (13.62%)

231

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ELV (Elevance Health) average time for price targets to be met?

On average it took 311.42 days on average for the stock forecasts to be realized with a an average price target met ratio 65.57

Which analyst has the current highest performing score on ELV (Elevance Health) with a proven track record?

LISA GILL

Which analyst has the most public recommendations on ELV (Elevance Health)?

Lisa Gill works at JPMORGAN and has 19 price targets and 11 ratings on ELV

Which analyst is the currently most bullish on ELV (Elevance Health)?

Scott Fidel with highest potential upside - $337.91

Which analyst is the currently most reserved on ELV (Elevance Health)?

Robert Jones with lowest potential downside - -$79.74

Elevance Health in the News

Elevance Health, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. July 11, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) investors of a class action representing investors that bought securities between April 18, 2024 and October 16,...

Validea Detailed Fundamental Analysis - ELV

Below is Validea’s guru fundamental report for ELEVANCE HEALTH INC (ELV). Of the 22 guru strategies we follow, ELV rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have strong momentum and high net payout yields. ELEVANCE HEALTH INC...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?